Literature DB >> 24971421

Health behaviors among testicular cancer survivors.

Matthew J Reilley1, Linda A Jacobs, David J Vaughn, Steven C Palmer.   

Abstract

BACKGROUND: With modern treatment, more than 95% of American men who are diagnosed with testicular cancer will be cured. Although there is growing evidence that these individuals may face heightened risk of cardiovascular disease after chemotherapy, there is a paucity of research to objectively classify health-promoting behaviors in this population and to identify the barriers to improving their health behaviors.
OBJECTIVES: To identify health behavior patterns in a group of testicular cancer survivors (TCSs) and the barriers to more positive health behaviors and to examine the relationship between barriers, health behaviors, and quality of life (QOL).
METHODS: TCSs from the Pennsylvania State Cancer Registry who had been diagnosed during 1990-2005 completed a comprehensive survey about QOL, health behaviors, and barriers to optimal healthy behaviors. QOL, health behaviors, and the barriers were assessed for 189 respondents.
RESULTS: Smoking (25%), risky drinking (35%), elevated body-mass index (83%), poor diet (95% did not meet the guidelines for fruit and vegetable intake), and inadequate exercise (50%) were common. Barriers to achieving optimal health behaviors were categorized as either cancer-related or competing demands. Cancer-related barriers contributed to worse physical QOL, whereas competing demands related to worse mental-health-related QOL. LIMITATIONS: Our sample size was moderate and self-selected. In addition, we used self-reports rather than the more standardized observation or interview-based data collection.
CONCLUSION: TCSs demonstrate behaviors that put them at increased risk for future cardiovascular disease and complications. Interventions aimed at reducing tobacco and risky alcohol use and improving dietary and physical activity levels are needed. FUNDING/SPONSORSHIP: NCI grant number 1R03CA124217; the Livestrong Foundation. DISCLOSURES: The authors have no disclosures.

Entities:  

Year:  2014        PMID: 24971421     DOI: 10.12788/jcso.0033

Source DB:  PubMed          Journal:  J Community Support Oncol        ISSN: 2330-7749


  7 in total

1.  Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Authors:  Thierry Gil; Spyridon Sideris; Fouad Aoun; Roland van Velthoven; Nicolas Sirtaine; Marianne Paesmans; Lieveke Ameye; Ahmad Awada; Daniel Devriendt; Alexandre Peltier
Journal:  Mol Clin Oncol       Date:  2016-07-14

2.  Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Authors:  Chunkit Fung; Howard D Sesso; Annalynn M Williams; Sarah L Kerns; Patrick Monahan; Mohammad Abu Zaid; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair J Beard; Christian K Kollmannsberger; Ryan Cook; Sandra Althouse; Shirin Ardeshir-Rouhani-Fard; Steve E Lipshultz; Lawrence H Einhorn; Sophie D Fossa; Lois B Travis
Journal:  J Clin Oncol       Date:  2017-02-27       Impact factor: 44.544

3.  Mental Health in Urologic Oncology.

Authors:  Danyon Anderson; Abrahim N Razzak; Matthew McDonald; David Cao; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-08-20

4.  Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Authors:  Sarah L Kerns; Chunkit Fung; Patrick O Monahan; Shirin Ardeshir-Rouhani-Fard; Mohammad I Abu Zaid; AnnaLynn M Williams; Timothy E Stump; Howard D Sesso; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair Beard; Robert A Huddart; Jeri Kim; Christian Kollmannsberger; Deepak M Sahasrabudhe; Ryan Cook; Sophie D Fossa; Lawrence H Einhorn; Lois B Travis
Journal:  J Clin Oncol       Date:  2018-04-04       Impact factor: 44.544

5.  Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study.

Authors:  Anne H Blaes; Daniel A Mulrooney; Rachel Isaksson Vogel; Anna Solovey; Robert Hebbel; Bruce A Peterson; Joseph P Neglia; Carter Biewen; Suma H Konety; Daniel A Duprez
Journal:  Vasc Health Risk Manag       Date:  2018-09-10

6.  Health-Promoting Lifestyle in Colorectal Cancer Survivors: A Qualitative Study on the Experiences and Perspectives of Colorectal Cancer Survivors and Healthcare Providers.

Authors:  Elahe Ramezanzade Tabriz; Monir Ramezani; Abbas Heydari; Seyed Amir Aledavood
Journal:  Asia Pac J Oncol Nurs       Date:  2021-10-04

7.  Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.

Authors:  Vaibhav Agrawal; Paul C Dinh; Chunkit Fung; Patrick O Monahan; Sandra K Althouse; Kelli Norton; Clint Cary; Lawrence Einhorn; Sophie D Fossa; Nabil Adra; Lois B Travis
Journal:  JNCI Cancer Spectr       Date:  2019-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.